ArticleCureus2026
Clinical Outcomes of Robotic-Assisted Gynecologic Surgery: A Single-Center 70-Case Series Experience.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Robotic-assisted surgery has emerged as an advanced minimally invasive approach in gynecology, offering enhanced visualization, precision, and ergonomics. However, real-world clinical data from Indian centers, particularly using indigenously developed robotic platforms, remain limited. Objective This study aims to evaluate the spectrum of indications, perioperative outcomes, and robotic-assisted gynecologic procedures performed with the SSI Mantra 3 Surgical Robotic System (SS Innovations International Inc., Gurugram, India) at a tertiary care center in India. Methods This retrospective case series included 70 consecutive patients who underwent robotic-assisted gynecologic surgery between August and December 2025. Procedures were performed using the SSI Mantra™ robotic system and included robotic hysterectomy (RH), robotic myomectomy (RM), and robotic cystectomy (RC) for benign gynecologic indications. Demographic variables, operative parameters (operative time, docking time, console time), estimated blood loss, length of hospital stay, and perioperative complications were analyzed using descriptive statistics. Results Of the 70 procedures, RH was the most common (31 cases, 44%), followed by RC (20 cases, 29%) and RM (19 cases, 27%). Patients undergoing RH were older than those in RM and RC, while body mass index was comparable across groups. RC demonstrated the shortest operative time (60.3 ± 18.5 minutes), lowest estimated blood loss (28.3 ± 39.6 mL), and shortest hospital stay (2.3 ± 0.8 days). RH had the longest operative time (119.3 ± 44.0 minutes) but remained associated with acceptable blood loss (113.8 ± 66.9 mL) and short hospitalization (2.7 ± 0.8 days). No intraoperative or postoperative complications were observed in any group. Conclusion Robotic-assisted gynecologic surgery using the SSI Mantra™ system is safe, feasible, and effective across a broad range of benign gynecologic conditions. The favorable perioperative outcomes, minimal blood loss, short hospital stay, and absence of complications support the integration of this indigenous robotic platform into contemporary minimally invasive gynecologic practice in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.